Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed
→ Ron Philip has stepped down as CEO at Roche’s Spark to run the show at Orbital Therapeutics, an RNA biotech tied to Beam Therapeutics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
